Conference Conversations: HIV Pharmacist Perspectives from CROI 2022
In this episode, Fidelia Bernice, PharmD, and Jennifer Cocohoba, PharmD, share insights on new HIV data from CROI 2022, including:Islatravir tissue and plasma distribution after monthly oral dosingPha...
15 Mar 202219min
Lessons From Lockdown: Viral Hepatitis Testing and Treatment in the COVID-19 Era—Audio Recap
In this episode, Jordan J. Feld, MD, MPH, and Nancy Reau, MD, share lessons learned in the testing and treatment of viral hepatitis in the COVID-19 era, including:Global impact of the COVID-19 pandemi...
14 Mar 202234min
Key Decisions in HIV Care: ART Considerations in the Inpatient Setting
In this episode, Jason Schafer, PharmD, MPH, explores recommendations and data on managing antiretroviral therapy (ART) in the inpatient setting.Listen as he gives his perspectives on:Antiretroviral s...
14 Mar 202217min
Key Decisions in HIV Care: Data on Long-Acting Injectable PrEP
In this episode, Jason Schafer, PharmD, MPH, explores the data for long-acting injectable pre-exposure prophylaxis (PrEP).Listen as he gives his perspectives on the:PrEP pipeline and the importance of...
14 Mar 202217min
Key HIV Studies Influencing My Practice Following CROI 2022—Audio Recap
In this episode, Daniel R. Kuritzkes, MD, and David A. Wohl, MD, discuss new HIV data from CROI 2022, including:Prevention strategiesLA therapiesSecond-line therapiesThe VISEND study comparing doluteg...
14 Mar 202246min
Monitoring and Treating Patients Coinfected With HBV and HDV
Hepatitis delta virus (HDV) only exists in patients with hepatitis B virus (HBV) coinfection. In part 1 of this 2-part podcast series, hear Heiner Wedemeyer, MD, and Cihan Yurdaydin, MD, discuss their...
10 Mar 202220min
Starting HBV Treatment in Pregnancy: Conversations Between Patient and Physician #3
Episode 3 of this series features Anna Cristina L. dela Cruz, MD, in conversation with patient Melody Cheng about Melody’s decision to start hepatitis B virus (HBV) antiviral therapy during pregnancy....
7 Mar 202211min
Hepatitis Delta Treatment: Where We Are and Where We Are Headed
Treatment options for hepatitis delta virus (HDV) are lacking, but many exciting agents are under investigation. Hear Drs Nancy Reau and Stefan Zeuzem discuss their thoughts on up-and-coming agents fo...
3 Mar 202217min
